Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$423M |
| 2 |
CS
Credit Suisse Group
CS
|
+$261M |
| 3 |
Barclays
BCS
|
+$240M |
| 4 |
ABB
ABB Ltd
ABB
|
+$161M |
| 5 |
Trip.com Group
TCOM
|
+$113M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lloyds Banking Group
LYG
|
+$230M |
| 2 |
SI
SIEMENS AKTIENGESELLSCHAFT ADS
SI
|
+$162M |
| 3 |
BF
BASF AKTIENGESELLT ADS(RP1 ORD
BF
|
+$84M |
| 4 |
BHP
BHP
|
+$60.3M |
| 5 |
SUSQ
SUSQUEHANNA BANCSHARES INC
SUSQ
|
+$42.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.7% |
| 2 | Healthcare | 13.73% |
| 3 | Technology | 13.21% |
| 4 | Industrials | 7.16% |
| 5 | Consumer Discretionary | 6.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Vanguard FTSE Europe ETF
VGK
$30.8B
| $21.5M | 0.04% |
410,176
+4,910
| +1% | +$263K |
|
|
NTUS
202
DELISTED
Natus Medical Inc
NTUS
| $21.1M | 0.04% |
585,730
+37,235
| +7% | +$1.25M |
|
203
Ecopetrol
EC
$35B
| $20.9M | 0.04% |
1,222,573
+159,518
| +15% | +$3.8M |
|
|
SGI
204
Somnigroup International
SGI
$14.1B
| $20.6M | 0.04% |
1,502,960
-46,780
| -3% | -$638K |
|
|
FRC
205
DELISTED
First Republic Bank
FRC
| $20.6M | 0.04% |
394,334
-4,589
| -1% | -$231K |
|
206
Ameriprise Financial
AMP
$48.1B
| $19.9M | 0.04% |
150,224
-11,766
| -7% | -$1.49M |
|
207
COPT Defense Properties
CDP
$4.35B
| $19.7M | 0.04% |
694,338
-18,755
| -3% | -$516K |
|
208
Mastercard
MA
$510B
| $19.4M | 0.04% |
224,616
+3,122
| +1% | +$255K |
|
209
Invesco S&P 500 Top 50 ETF
XLG
$10.5B
| $18.9M | 0.04% |
1,330,770
+69,720
| +6% | +$977K |
|
210
Zimmer Biomet
ZBH
$18.4B
| $18.6M | 0.04% |
169,045
-6,178
| -4% | -$651K |
|
211
Gerdau
GGB
$9.74B
| $18.6M | 0.04% |
6,583,985
+1,368,783
| +26% | +$4.54M |
|
212
Omnicell
OMCL
$1.69B
| $18.5M | 0.04% |
559,000
+66,522
| +14% | +$2.06M |
|
213
CONMED
CNMD
$1.41B
| $18.2M | 0.04% |
405,705
-8,105
| -2% | -$340K |
|
214
3M
MMM
$90.8B
| $17.6M | 0.04% |
127,759
+124,474
| +3,789% | +$16M |
|
|
CYN
215
DELISTED
CITY NATIONAL CORPORATION
CYN
| $17.5M | 0.04% |
216,818
+610
| +0.3% | +$47.1K |
|
216
Vanguard FTSE Developed Markets ETF
VEA
$230B
| $17.2M | 0.04% |
452,813
+173,110
| +62% | +$6.7M |
|
|
TSS
217
DELISTED
Total System Services, Inc.
TSS
| $17.1M | 0.04% |
502,986
+123,240
| +32% | +$3.99M |
|
218
State Street Health Care Select Sector SPDR ETF
XLV
$42.2B
| $16.9M | 0.04% |
247,355
+12,557
| +5% | +$840K |
|
219
Kroger
KR
$35.4B
| $16.5M | 0.03% |
514,670
-104,610
| -17% | -$3.03M |
|
|
SNDK
220
DELISTED
SANDISK CORP
SNDK
| $16.3M | 0.03% |
166,197
-30,804
| -16% | -$2.95M |
|
|
STJ
221
DELISTED
St Jude Medical
STJ
| $15.8M | 0.03% |
243,188
-12,475
| -5% | -$803K |
|
222
Cullen/Frost Bankers
CFR
$10.3B
| $15.7M | 0.03% |
222,553
-2,254
| -1% | -$170K |
|
|
PCH
223
DELISTED
PotlatchDeltic
PCH
| $15.7M | 0.03% |
374,101
| – | – |
|
224
Fidelity National Information Services
FIS
$23.8B
| $15.1M | 0.03% |
242,190
-1,402
| -0.6% | -$82.4K |
|
225
Equifax
EFX
$20.7B
| $14.9M | 0.03% |
184,712
-24,268
| -12% | -$1.88M |
|
Similar funds
Ken Fisher's Q4 2014 Portfolio in Review
As of Q4 2014, Ken Fisher held 664 positions worth $48.4B, up 3.1% from $46.9B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Ken Fisher's Q4 2014 filing shows 80 new, 228 increased, 245 reduced and 44 closed positions. Its largest new stake was UBS Group: 24,721,456 shares worth $422M. The largest sale was Lloyds Banking Group, an estimated $230M.
By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Technology.
- Ken Fisher's largest Q4 2014 buy was UBS Group: 24,721,456 shares worth $422M.
- Ken Fisher added most to Credit Suisse Group in Q4 2014, an estimated $261M increase.
- Ken Fisher's biggest Q4 2014 reduction was Lloyds Banking Group, cutting an estimated $230M.
- Ken Fisher fully exited SUSQUEHANNA BANCSHARES INC in Q4 2014, selling an estimated $42.8M.
- Ken Fisher's ten largest holdings make up 22% of its $48.4B portfolio in Q4 2014.
- Ken Fisher opened 80 new positions and closed 44 in Q4 2014.
- Ken Fisher's portfolio value rose 3.1% quarter-over-quarter to $48.4B.
Based on Fisher Asset Management's 13F filing for Q4 2014, filed 29 Jan 2015.